VLP Purification Patent granted in US

ARTES is pleased to announce the enlargement of the protective aera for their VLP development  and production platform patent . The patent is about a “Method for Separating of Viruslike Particles from a Cell Suspension” and now valid in Europe and US.

VLP purification patent granted in EU

Artes is pleased to announce the issuance of a new patent for their VLP development  and production platform. The patent is about a “Method for Separating of Viruslike Particles from a Cell Suspension”.  

ARTES and Burnet Institute publish data on new malaria vaccine candidates

For more information: Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of Plasmodium falciparum Is Immunogenic and Induces Functional Antibody Responses in Mice.